Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Nature cancer
2026
Added value of ctDNA testing with primary treatment for metastatic prostate cancer prognosis.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Added value of ctDNA testing with primary treatment for metastatic prostate cancer prognosis. | OpenQuestion